Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Large study will evaluate PTH-bisphosphonate combination therapy in osteoporosis

May 31, 2000

AHP discloses new compounds for treating metabolic disorders related to insulin resistance

May 26, 2000

Growth hormone secretagogues in early development at Pfizer

May 23, 2000

Metabolex signs second diabetes collaboration with Parke-Davis

May 23, 2000

Beta3-adrenoceptor agonists now claimed for inhibiting uterine contractions

May 22, 2000

Orlistat reduces progression to type II diabetes in obese adults

May 22, 2000

Benefits of Fosamax continue with long-term use

May 22, 2000

Imidazolones targeting Y5 receptors described by BMS as anorectic agents

May 19, 2000

Lilly's Evista receives additional approval in E.U. for the treatment of osteoporosis

May 19, 2000

Novel therapeutic approaches for diabetic nephropathy explored

May 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...